High Point Advisor Group LLC Dynavax Technologies Corp Transaction History

High Point Advisor Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$3.73 - $5.6 $59,680 - $89,600	-16,000 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$4.32 - $11.7 $432 - $1,170	100 Added 0.63%	16,000 $66,000
Q2 2020 Aug 13, 2020	BUY	$2.94 - $9.1 $1,470 - $4,550	500 Added 3.25%	15,900 $132,000
Q1 2020 May 01, 2020	BUY	$2.27 - $6.2 $34,839 - $95,157	15,348 Added 29515.38%	15,400 $52,000
Q1 2020 Apr 27, 2020	SELL	$2.27 - $6.2 $28,710 - $78,417	-12,648 Reduced 99.59%	52 $15.4 Million
Q4 2019 Feb 13, 2020	BUY	$3.46 - $6.93 $854 - $1,711	247 Added 1.98%	12,700 $77,000
Q3 2019 Nov 12, 2019	BUY	$2.69 - $4.85 $2,714 - $4,893	1,009 Added 8.82%	12,453 $65,000
Q2 2019 Aug 15, 2019	BUY	$3.65 - $7.89 $41,770 - $90,293	11,444 New	11,444 $38,000

286

127M

546K

377K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.62B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.